Additionally, we showed that SIRT1 is activated by BCR-ABL1 transformation and that knockout of Sirt1 inhibits CML development in young mice [40, 56]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.